NEW YORK (GenomeWeb News) – Arrayit said today that Sandia National Laboratories will use the company’s nanotechnology platform to develop microarrays for use in anti-bioterror efforts.

Sandia Labs will use Arrayit’s nanoliter technology to develop microarrays, biosensors, and other sensor tools for use in detecting biological and chemical agents that could be part of a terrorism event.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.